Good news in University of Colorado chemical accident
Nov30

Good news in University of Colorado chemical accident

The Colorado Daily reported this evening on a chemical explosion that injured an unidentified PhD student at the University of Colorado Engineering Center in Boulder. Few details are available now but don’t let the photos of the firefighters put you off – the accident could have been far worse. Emergency crews evacuated the University of Colorado Engineering Center this afternoon after chemicals exploded in a beaker and...

Read More
DEA acts on naphthoylindoles and 3-phenylcyclohexanols in synthetic marijuana
Nov28

DEA acts on naphthoylindoles and 3-phenylcyclohexanols in synthetic marijuana

A slightly different version of this post appeared yesterday at my Take As Directed blog. Just before we in the US took off for the holiday, the US Drug Enforcement Agency released notice of “emergency scheduling” of synthetic cannabimimetic compounds currently sold in herbal incense products. Products like K2, Spice, Black Mamba, and pure compounds such as JWH-018 have been a boon for convenience stores, head shops, and...

Read More

Elegant defense of the humanities by noted structural biologist

This crosspost first appeared on 20 November 2010 at the PLoS Blogs home of my free-range blog, Take As Directed. I’m not in the protein crystallography field. Instead, the way that I came to learn of Gregory Petsko at Brandeis University was via a tweet from literary agent, Ted Weinstein, about an hour ago. Ted’s tweet referred me to an open letter that Dr. Petsko wrote in Genome Biology to the President of SUNY-Albany,...

Read More
Racism charged in DePaul chemistry tenure denial
Nov21

Racism charged in DePaul chemistry tenure denial

Organometallics chemist and NSF CAREER awardee, Dr. Quinetta D. Shelby, has been denied tenure in the Department of Chemistry at DePaul University even after an institutional appeals committee determined that her negative departmental review was flawed. According to a note at Inside Higher Ed on Thursday: Supporters of Quinetta Shelby released documents Wednesday suggesting bias in her tenure denial at DePaul University. Shelby is the...

Read More

Apixaban trial halted, eight others continue

After writing this week about the new, direct-acting antithrombotic drugs that threaten to replace the stalwart anticoagulant, warfarin, comes news that the joint BMS/Pfizer development of apixaban has hit a snag. From Jonathan Rockoff and Kathy Shwiff in the Wall Street Journal: Pfizer Inc. and Bristol-Myers Squibb Co. said they’ve halted one the key trials for an experimental blood-thinning drug that is one of their brightest...

Read More